Edmund P. Harrigan, M.D.

Edmund Harrigan has 28 years of pharmaceutical industry experience serving in various executive leadership positions across Business Development, Clinical, Drug Safety, and Regulatory affairs. Throughout his career, Dr. Harrigan spent 18 years at Pfizer, most recently as Senior Vice President of Worldwide Safety and Regulatory. In this role, he led a 3,500-person team in 80 … Read More

William Grossman, M.D., Ph.D.

Bill Grossman has an extensive background in the development of cancer immunotherapies and joined Bellicum in 2018 from Genentech/Roche. In his most recent role at Genentech, Dr. Grossman served as the Group Medical Director, Cancer Immunotherapy, where he led the global clinical development of TECENTRIQ® in gastrointestinal cancers and of cancer immunotherapy combinations across all … Read More

Paul Woodard, M.D.

Paul Woodard joined Bellicum in November 2017 as Vice President, Clinical Development and is responsible for clinical development strategy, clinical trial design, and medical oversight of the Company’s portfolio. He most recently served as Global Development Team Leader for TECENTRIQ® in Hematology at Genentech. Prior to Genentech, Dr. Woodard held positions of increasing responsibility in … Read More

Gregory Naeve, Ph.D.

Gregory Naeve joined Bellicum in August 2017 as Chief Business Officer to lead product and portfolio strategy as well as business development for the Company. Previously, Dr. Naeve served as the ImmunoOncology & Cell Therapy Lead for Pfizer’s External Research and Development Unit. During his tenure, he was a key member of the executive team responsible … Read More

Rosie Williams, CPA

Rosie Williams joined Bellicum in 2014 and serves as Vice President of Finance and Controller.  She is a Certified Public Accountant with over 30 years of experience in finance and accounting.  She began her career working in the public accounting field at Arthur Andersen and later held positions of increasing responsibility with various companies and industries, including … Read More

Aaron Foster, Ph.D.

Aaron Foster is Vice President of Product Discovery at Bellicum Pharmaceuticals. He leads the CAR and TCR gene-modified T cell programs that are developing systems for controlling T cell behavior in vivo using molecular switch technology. Prior to joining Bellicum in 2012, Dr. Foster was an Assistant Professor at Baylor College of Medicine at the Center … Read More

Jim Daly

Mr. Daly has over 30 years of experience leading U.S. and global businesses in the biopharmaceutical industry and currently serves as a Director of ACADIA Pharmaceuticals, Halozyme Therapeutics, and Chimerix, Inc. Most recently, Mr. Daly served as Executive Vice President and Chief Commercial Officer at Incyte Corporation from 2012 to 2015, where he was instrumental in … Read More

Alan K. Smith, Ph.D.

Alan Smith, Executive Vice President, Technical Operations, joined Bellicum in October 2015. He has over 30 years of experience in R&D, Manufacturing and Quality roles in cellular therapeutics and previously served as Bellicum’s Senior Vice President of Manufacturing. Prior to that, Dr. Smith was Vice President of Research & Development and Cellular Therapeutics for LifeNet Health, … Read More

Scott Cullison

Scott Cullison joined Bellicum in August 2015 as Vice President of Commercial Planning and Program Management. He brings over 13 years of biotech and pharmaceutical industry experience, including expertise in business development, alliance management, product management, commercialization, R&D program leadership and strategic planning. Throughout his career, Mr. Cullison held positions of increasing responsibility at Targacept, … Read More

Steven Toler, Pharm.D., Ph.D.

Steve Toler joined Bellicum in May of 2015 as Vice President of Pharmaceutical Development. He has over 22 years of Pharmaceutical R&D experience, beginning his career with Pfizer in 1993. Most recently, Steve was Vice President of Translational Medicine at Targacept in Winston-Salem, North Carolina. Steve holds a Pharm.D. degree from Mercer University and a … Read More